Page last updated: 2024-08-20

dextrothyroxine and fluvoxamine

dextrothyroxine has been researched along with fluvoxamine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	4 (100.00)	2.80

Authors

Authors	Studies
Anderson, B; Avula, N; Belani, HK; Biros, M; Boulware, DR; Bramante, CT; Buse, JB; Cohen, K; Erickson, SM; Fenno, SL; Fricton, R; Hagen, AA; Hartman, KM; Huling, JD; Ingraham, NE; Karger, AB; Klatt, NR; Lee, S; Liebovitz, DM; Lindberg, S; Luke, DG; Murray, TA; Nicklas, JM; Odde, DJ; Patel, B; Proper, JL; Pullen, MF; Puskarich, MA; Rao, V; Reddy, NV; Saveraid, HG; Sherwood, NE; Siegel, LK; Thompson, JL; Tignanelli, CJ; Tordsen, WJ; Zaman, A	1
Misra, S; Shukla, AK	1
Boulware, DR; Bramante, CT; Buse, JB	1
Anderson, BJ; Beckman, KB; Belani, HK; Bhat, NS; Boulware, DR; Bramante, CT; Buse, JB; Cohen, K; Erickson, SM; Fenno, SL; Griffiths, G; Hartman, KM; Huling, JD; Karger, AB; Klatt, NR; Liebovitz, DM; Lindberg, SM; Mehta, T; Murray, TA; Nicklas, JM; Odde, DJ; Patel, B; Proper, JL; Pullen, M; Puskarich, MA; Rose, MR; Sherwood, NE; Siegel, LK; Thompson, JL; Tignanelli, CJ; Wirtz, EL	1

Trials

2 trial(s) available for dextrothyroxine and fluvoxamine

Article	Year
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. The New England journal of medicine, 2022, 08-18, Volume: 387, Issue:7 Topics: Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Double-Blind Method; Female; Fluvoxamine; Humans; Hypoxia; Ivermectin; Male; Metformin; Middle Aged; Obesity; Overweight; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2	2022
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. The Lancet. Infectious diseases, 2023, Volume: 23, Issue:10 Topics: Adult; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Fluvoxamine; Humans; Incidence; Ivermectin; Male; Metformin; Middle Aged; Outpatients; Post-Acute COVID-19 Syndrome; Pregnancy; SARS-CoV-2; Treatment Outcome	2023

Article

Year

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

The New England journal of medicine, 2022, 08-18, Volume: 387, Issue:7

Topics: Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Double-Blind Method; Female; Fluvoxamine; Humans; Hypoxia; Ivermectin; Male; Metformin; Middle Aged; Obesity; Overweight; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2

2022

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.

The Lancet. Infectious diseases, 2023, Volume: 23, Issue:10

Topics: Adult; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Fluvoxamine; Humans; Incidence; Ivermectin; Male; Metformin; Middle Aged; Outpatients; Post-Acute COVID-19 Syndrome; Pregnancy; SARS-CoV-2; Treatment Outcome

2023

Other Studies

2 other study(ies) available for dextrothyroxine and fluvoxamine

Article	Year
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. The New England journal of medicine, 2022, 12-15, Volume: 387, Issue:24 Topics: COVID-19; Fluvoxamine; Humans; Ivermectin; Metformin	2022
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply. The New England journal of medicine, 2022, 12-15, Volume: 387, Issue:24 Topics: COVID-19; Fluvoxamine; Humans; Ivermectin; Metformin	2022